FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.
|Articles|June 16, 2021
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of June 16, 2021
Author(s)Sydney Jennings
Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 vaccinations, cases, and deaths in the US and on cases and deaths worldwide.
Advertisement
How many people in the US have been vaccinated against COVID-19?
According to the US
• 52.7% of total US population has received at least 1 dose
• 44.1% of total US population is fully vaccinated
• 44.1% of total US population is fully vaccinated
The 5 states with the highest percentage of population fully vaccinated are:
1. Vermont: 62.9%
2. Maine: 58.8%
3. Massachusetts: 58.3%
4. Connecticut: 57.9%
5. Rhode Island: 55.7%
2. Maine: 58.8%
3. Massachusetts: 58.3%
4. Connecticut: 57.9%
5. Rhode Island: 55.7%
How many cases of COVID-19 have been confirmed in the US?
According to the
• 33 491 891 confirmed cases
• 600 478 deaths
• 600 478 deaths
The 5 states with the highest total confirmed cases are:
1. California: 3 804 348
2. Texas: 2 980 004
3. Florida: 2 344 321
4. New York: 2 110 201
5. Illinois: 1 388 261
2. Texas: 2 980 004
3. Florida: 2 344 321
4. New York: 2 110 201
5. Illinois: 1 388 261
Deaths: California has the most deaths due to COVID-19 with 63 217 reported fatalities, followed by New York with 53 577, and Texas with 51 968.
How many cases of COVID-19 have been confirmed globally?
Globally, there have been 176 758 434 confirmed cases, 3 824 921 deaths, and 2 438 620 910 vaccine doses administered.
Advertisement
Related to this article
A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.
Pre-existing antibodies to common microbes predicted COVID-19 vaccine response strength in healthy and immunosuppressed adults.
FDA approved bictegravir/lenacapavir for adults with suppressed HIV-1 and no known or suspected component resistance.
FDA expands dolutegravir dispersible tablets to children with HIV-1 weighing at least 2 kg, including eligible term newborns.
Stroke incidence in adults aged 20–54 nearly doubled from 1993–1994 to 2020, driven largely by ischemic stroke, while 30-day fatality declined, according to new research.
The FDA has approved insulin efsitora alfa-gobe (Onswik) for adults with type 2 diabetes.
New research links type 2 diabetes and genetic risk to MASLD cirrhosis before 50, warning age-based fibrosis scores can miss severe disease.
Advertisement
Advertisement
Trending on Patient Care Online
1
GLP-1 RAs for Weight Management: A Primary Care Approach to Risk and Monitoring
2
Stroke Incidence Nearly Doubled Among Adults Younger Than 55 Over 3 Decades
3
Safety, Dosing, and Drug Interactions for Dextromethorphan-Bupropion in Agitation
4
FDA Approves Sotatercept-csrk Label Update for Newly Diagnosed PAH
5